Omega Therapeutics Announces Election of Richard N. Kender to Board of Directors

June 24, 2024

https://www.globenewswire.com/news-release/2024/06/24/2902873/0/en/Omega-Therapeutics-Announces-Election-of-Richard-N-Kender-to-Board-of-Directors.html

CAMBRIDGE, Mass., June 24, 2024 (GLOBE NEWSWIRE) — Omega Therapeutics, Inc. (Nasdaq:OMGA) (“Omega”), a clinical-stage biotechnology company pioneering the development of a new class of programmable epigenomic mRNA medicines, today announced the election of Richard N. Kender to its Board of Directors following its annual meeting of stockholders. Mr. Kender’s industry knowledge and proven expertise in corporate finance and business development spanning both large pharmaceutical and emerging biotech companies will be instrumental in supporting the Company’s business objectives.

Read more at globenewswire.com

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.